A team from Tru-D SmartUVC is scheduled to speak with healthcare professionals from around the country at the Association for the Healthcare Environment's EXCHANGE conference Sept. 20-23 at booth 107 in the Gaylord Texan Convention Center exhibit hall in Grapevine, Texas.
Tru-D leadership will be available to offer expert perspective on the role of Tru-D disinfection as a best practice in environmental hygiene and how Tru-D is easily adapted into existing workflow processes. Devices requiring positioning and monitoring by EVS staff still place the responsibility of terminal disinfection in human hands, risking human error, as well as increasing labor resources needed. Tru-D, equipped with sensor technology, is not only able to complete the job independently, but can also collect and report infection prevention data, which can be used by EVS leaders to monitor and track successful disinfection results.
With antibiotic resistance becoming a more common and deadly threat, health care leaders continue to hone in on the science and technology behind preventing hospital acquired infections and managing emerging pathogens. And, Tru-D SmartUVC is the only portable UV disinfection system that precisely measures reflected UVC emissions with Sensor360 technology and automatically calculates the pathogen-lethal UV dose required to terminally disinfect each room, dynamically compensating for room size, shape and other dose-altering variables including position of contents, windows, blinds and doors.
"Healthcare leaders are no longer asking what is UVC disinfection, instead they are asking how it will incorporate successfully into their facilities' workflow," says Chuck Dunn, president of Tru-D SmartUVC LLC. "Tru-D's ease-of-use and proven efficacy makes it the only choice for these progressive healthcare leaders. Very dangerous organisms can hide inside even the most thoroughly cleaned environments by EVS, but Tru-D takes the guess work out of disinfection by measuring the UVC dose produced by lamps that ensure the highest efficiency of germicidal energy delivery."
According to the Centers for Disease Control, hospital-acquired infections affect two million people every year resulting in nearly 100,000 deaths and $30 billion in medical costs. These staggering numbers are driving healthcare research institutions, like the CDC, to invest in studies toward solutions to this deadly problem. Tru-D was selected as the exclusive device for the most comprehensive UV disinfection study to date, Benefits of Enhanced Terminal Room Disinfection performed by the Duke Infection Control Outreach Network and funded by the CDC. The results on the $2 million landmark study will be presented at IDWeek 2015 in San Diego on Oct. 9.
Source: Tru-D SmartUVC